| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.32 | 0.04 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.05 |